|
DYNC1LI2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.532640E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.349800E-01 |
| Normal-vs-Stage2 |
2.980400E-01 |
| Normal-vs-Stage3 |
1.175960E-02 |
| Normal-vs-Stage4 |
1.677740E-03 |
| Stage1-vs-Stage2 |
1.460570E-01 |
| Stage1-vs-Stage3 |
1.338550E-03 |
| Stage1-vs-Stage4 |
2.616700E-04 |
| Stage2-vs-Stage3 |
4.281000E-01 |
| Stage2-vs-Stage4 |
2.017800E-01 |
| Stage3-vs-Stage4 |
4.530800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.460190E-01 |
| Normal-vs-AfricanAmerican |
1.932200E-01 |
| Normal-vs-Asian |
1.067380E-01 |
| Caucasian-vs-AfricanAmerican |
6.571200E-01 |
| Caucasian-vs-Asian |
8.743700E-02 |
| AfricanAmerican-vs-Asian |
7.804100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.110100E-02 |
| Normal-vs-Female |
6.391600E-01 |
| Male-vs-Female |
1.356840E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.953000E-01 |
| Normal-vs-Age(41-60Yrs) |
9.623000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.987570E-02 |
| Normal-vs-Age(81-100Yrs) |
2.990500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.621000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.734600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.124800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.363000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.500300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.009800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.660400E-03 |
| Normal-vs-Grade 2 |
4.970800E-01 |
| Normal-vs-Grade 3 |
2.734000E-02 |
| Normal-vs-Grade 4 |
4.77580000002309E-06 |
| Grade 1-vs-Grade 2 |
5.395900E-02 |
| Grade 1-vs-Grade 3 |
1.836630E-04 |
| Grade 1-vs-Grade 4 |
3.86019999965015E-07 |
| Grade 2-vs-Grade 3 |
4.622400E-04 |
| Grade 2-vs-Grade 4 |
3.15499999459234E-08 |
| Grade 3-vs-Grade 4 |
4.677500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.203800E-01 |
| Normal-vs-ccB subtype |
1.823960E-02 |
| ccA subtype-vs-ccB subtype |
6.28859999999287E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.319800E-01 |
| Normal-vs-N1 |
1.272300E-02 |
| N0-vs-N1 |
1.083350E-01 |
|
|
